| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.5 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.5 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.5 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.5 |